Table 1.
Docetaxel alone (n = 9) | Gefitinib + docetaxel (n = 9) | |
---|---|---|
Age (range; years) | 53.1 (35–69) | 56.3 (37–67) |
Weight/height | 70.4 kg/164 cm | 70.4 kg/164 cm |
Performance status | ||
WHO grade 0 | 5 | 4 |
WHO grade 1 | 3 | 4 |
WHO grade 2 | 1 | 1 |
Previous therapy for metastatic disease | ||
None | 1 | 5 |
Endocrine therapy | 6 | 3 |
Antracycline | 1 | 1 |